Loading insider details...
Beta
Latest Form 4 (Sep 9, 2026): Sale of 7,100 TARS shares, $640.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 9, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale | 7,100 | $640.9K |
| Sep 3, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale | 10,000 | $800.6K |
| Jun 22, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale | 4,582 | $280.6K |
| Mar 19, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale | 10,972 | $761.7K |
| Mar 17, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 66,274 | n/a |
| Mar 9, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/Award | 96,723 | n/a |
| Dec 30, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale | 5,443 | $448.6K |
| Dec 8, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Gift | 51,885 | n/a |
| Sep 26, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale | 6,000 | $332.2K |
| Aug 13, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale | 6,000 | $300.0K |